FDA clears $60M BioMarin drug-making plant expansion

BioMarin Pharmaceutical Inc.’s expanded manufacturing plant in Novato won approval from the Food and Drug Administration.
BioMarin (NASDAQ: BMRN) completed construction of the 21,800-square-foot “clean room” addition last year. It invested $60 million to expand the facility to about 70,000 square feet, including about 40,000 square feet of clean room space.
When production is up and running in the new space, a company spokesman said, BioMarin will have more than 100 new employees. Some of those new hires may already be on board, he said.